New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
10:19 EDTTDW, RGA, KING, CEQP, SHZ, OSK, MSTR, FI, AMP, WMT, THOR, LPI, FWM, TWOUOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: 2U (TWOU) downgraded to Neutral from Buy at Goldman... Ameriprise (AMP) downgraded to Equal Weight from Overweight at Morgan Stanley... Brown Forman downgraded to Neutral from Buy at ISI Group... Crestwood Equity (CEQP) downgraded to Market Perform from Outperform at Wells Fargo... Fairway Group (FWM) downgraded to Market Perform from Outperform at William Blair... Frank's International (FI) downgraded to Accumulate from Buy at Global Hunter... Hanger (HGR) downgraded to Neutral from Buy at SunTrust... King Digital (KING) downgraded to Sector Perform from Outperform at Pacific Crest... Laredo Petroleum (LPI) downgraded to Equal Weight from Overweight at Stephens... MicroStrategy (MSTR) downgraded to Sell from Hold at Drexel Hamilton... Oshkosh (OSK) downgraded to Neutral from Overweight at JPMorgan... Reinsurance Group (RGA) downgraded to Underweight from Equal Weight at Morgan Stanley... Thoratec (THOR) downgraded to Market Perform from Outperform at Northland... Tidewater (TDW) downgraded to Accumulate from Buy at Global Hunter... Wal-Mart (WMT) downgraded to Hold from Buy at Jefferies... Whiting USA Trust II (WHZ) downgraded to Sell from Hold at Stifel.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
October 8, 2015
16:39 EDTTHORSt. Jude Medical completes acquisition of Thoratec
Subscribe for More Information
10:00 EDTCEQPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:00 EDTTWOU2U weakness creates buying opportunity, says Pacific Crest
Subscribe for More Information
07:24 EDTCEQPCrestwood Equity downgraded to Underperform from Neutral at BofA/Merrill
Subscribe for More Information
October 7, 2015
16:29 EDTTHORThoratec shareholders approve acquisition of company by St. Jude Medical
Subscribe for More Information
06:42 EDTWMTWal-Mart price target lowered to $70 from $76 at Deutsche Bank
Subscribe for More Information
October 6, 2015
15:25 EDTMSTRAmazon cloud announcement unlikely to sink Splunk, analysts say
Amazon (AMZN) appears to be signaling an expanded presence in cloud-based data analytics, sending shares of incumbents in the space lower and prompting several analysts to weigh in on the e-commerce giant's potential impact. AMAZON CLOUD: Amazon is expected to announce a new "big data" analytics addition to Amazon Web Services, according to an October 4 Wall Street Journal report. The article follows the launch last week of Amazon Elasticsearch, adding further data crunching capabilities to the company's cloud computing platform. Commenting on the news, William Blair analyst Bhavan Suri said that Splunk (SPLK) investor concerns over Amazon are overblown. Elasticsearch is likely to remain primarily a document search platform rather than a direct competitor to Splunk's offerings, while Amazon's expected analytics announcement looks more likely to challenge Tableau (DATA) and Qlik (QLIK), the analyst argues. Meanwhile, FBR analyst Daniel Ives said that a tangential move into the data analytics space "makes a ton of strategic and financial sense" for Amazon, as the market is only about 10% penetrated despite aggressive expansion from Microstrategy (MSTR), IBM (IBM), Microsoft (MSFT), SAP (SAP), and others. That said, Ives cautioned that Amazon's ability to again disrupt the cloud space with this latest entry appear limited in the near term, with many companies already showing preference for pure-play analytics firms. Amazon may ultimately have to make a larger acquisition by picking up a Qlik, Tableau, or Splunk to gain traction, the analyst contended. PRICE ACTION: Splunk shares are down fractionally in afternoon trading after some earlier volatility, while Tableau and Qlik are showing respective losses of roughly 3.14% and 1.86%.
11:51 EDTWMTWal-Mart, Visa in talks to end $5B processing fees suit, Bloomberg says
Subscribe for More Information
October 5, 2015
15:15 EDTTHORStudy finds potential stroke risk with prosthetic heart valves
Subscribe for More Information
10:52 EDTTHORAnalysts downplay potential impact of St. Jude FDA warning letter
Shares of St. Jude Medical (STJ), a developer, manufacturer and distributor of cardiovascular medical devices, are slightly higher in morning trading after analysts said that the company's receipt of a U.S. Food and Drug Administration warning letter for its Atlanta facility "doesn't look that bad." WHAT'S NEW: On Friday afternoon, St. Jude Medical disclosed in a regulatory filing that it received a warning letter from the FDA, which related to "observed non-conformities" at its Atlanta facility, where it manufactures the CardioMEMS HF system. St. Jude said that the FDA had from June 8-26 inspected the company's Atlanta facility and that various devices of the company manufactured at its Atlanta plant were found to be "adulterated." The FDA also said certain of the company's manufacturing, packing, storage and installation practices "are not in conformity" to the current goods and manufacturing practice requirements. St. Jude said it would continue to manufacture and ship the product from the Atlanta facility and does not expect customer orders to be impacted. WHAT'S NOTABLE: In January 2013, the FDA sent St. Jude Medical a warning letter detailing concerns regarding processes at the company's Sylmar, California facility; the letter did not raise any safety concerns about St. Jude Medical products. The company later detailed efforts to correct problems found during the inspection at the plant, which makes heart defibrillator leads. ANALYST REACTION: Deutsche Bank analyst Kristen Stewart kept a Hold rating on the stock and said that the warning letter "doesn't seem that bad" because St. Jude does not expect any impact on its ability to fulfill or ship customer orders and does not expect a material financial impact relating to the matter. Stewart noted that the FDA "seems satisfied" with the remediation made and has not expressed concerns about the need for a product recall or stop shipment. Similarly, Piper Jaffray analyst Brooks West believes the warning letter will not have a commercial impact on the company, and that the cost of alleviating the FDA's observations "are limited." West has an Overweight rating and $84 price target on the stock. PRICE ACTION: St. Jude Medical is up 0.2% to $63.94 in morning trading. ANOTHER TO WATCH: Thoratec (THOR), which agreed in late July to be acquired by St. Jude Medical, is essentially flat at $63.45.
October 4, 2015
15:04 EDTOSKThales in talks to provide light armored vehicles for Australia, WSJ says
Australia is in advanced talks to purchase a number of Hawkei light armored vehicles from French defense firm Thales, reports the Wall Street journal, citing two people familiar with the matter. Companies in the space include BAE Systems (BAESY), Lockheed Martin (LMT), and Oshkosh (OSK). Reference Link
October 2, 2015
11:32 EDTWMTAnalyst sees Amazon becoming #2 player in $425B consumables market
Amazon (AMZN) will advance to the number two position in the $425B U.S. consumables market, excluding food and beverages, by 2018, research firm Cowen predicted in a note to investors today. WHAT'S NEW: Amazon's "multi platform approach around Prime" is enabling it to gain share in the U.S. market for goods including personal care, household, pet and baby products, Cowen analyst John Blackledge stated. Specifically, the e-commerce giant is effectively using its Amazon Prime, Amazon Prime Now, Amazon Pantry and Amazon Fresh offerings to sell consumables and it has significantly increased the number of fulfillment centers it operates, lowering its delivery times, according to Blackledge. The company's delivery times are now "well ahead of (the) competition," the analyst reported. The e-commerce giant's strategy in the consumables market appears to be working, as Cowen's proprietary data indicates that the company is gaining share in the category, Blackledge wrote. Additionally, Amazon is beginning to attract more customers from Wal-Mart (WMT) and Target (TGT), he believes. PRICE ACTION: In late morning trading, Amazon slipped 0.4% to $518.70.
10:15 EDTWMTWal-mart to cut 450 jobs at Atlanta headquarters, Reuters reports
Subscribe for More Information
08:21 EDTWMTAmazon to be number two player in U.S. consumables by 2018, says Cowen
John Blackledge and the research team at Cowen project that (AMZN) will grow to be the number two player in the $425B market for U.S. consumables - which they define as personal care, household, pet and baby products - by 2018. The firm expects Amazon to use its multi-platform approach, centered around Prime, to help the e-commerce giant gain share in consumables at the expense of Wal-Mart (WMT), Target (TGT), Walgreens (WBA) and CVS Health (CVS). Cowen has Outperform ratings on Amazon and Target and a Market Perform rating on shares of Wal-Mart.
06:51 EDTWMTWal-Mart Chile eyes shopping center chain sale, Reuters says
Wal-Mart Chile is eyeing a sale of its chain of shopping centers in an effort to focus on its larger supermarket operations in Chile, Reuters reports. The plan would involve the sale of 10 "Espacio Urbano" centers throughout the country, totaling roughly 250,000 square meets, the report says. Reference Link
October 1, 2015
10:37 EDTWMTBofA/Merrill's Top 10 US Ideas for Q4 2015
Subscribe for More Information
08:10 EDTWMTAmerican Express cards now accepted at Sam's Club
Subscribe for More Information
06:16 EDTWMTWal-Mart to lay off hundreds of employees at Arkansas headquarters, Reuters says
Wal-Mart plans to cut hundreds of jobs at its headquarters in Arkansas in an effort to pare costs, Reuters reports, citing people familiar with the matter. Fewer than 500 employees are expected to have their employment terminated and an announcement could come as early as Friday, the report says. Reference Link
September 30, 2015
18:07 EDTTHORS&P announces changes to the S&P 400, 500 indices
S&P 500 constituent Joy Global (JOY) will replace Thoratec (THOR) in the S&P MidCap 400, and Verisk Analytics (VRSK) will replace Joy Global in the S&P 500 after the close of trading on Wednesday, October 7. S&P 500 constituent St. Jude Medical (STJ) is acquiring Thoratec in a deal expected to be completed on or about that date, pending final approvals. Joy Global has a market capitalization more representative of the mid-cap market space.
17:19 EDTTHORJoy Global to replace Thoratec in S&P 400 as of 10/7 close
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use